Cargando…

Impact of the use of antibiotics on the clinical response to immune checkpoint inhibitors in patients with non-small cell lung cancer

OBJECTIVES: Recent research suggests that the use of antibiotics could reduce the efficacy of checkpoint inhibitors, in addition to other well-known factors. It could be due to gut microbiota modification, which impact over the immune system response. However, the information available so far is con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barbosa, Cristina Martinez-Mugica, Lletí, Ana Cristina Cercós, Sánchez, Rubén Pampín, Román, Cristina Durán, Alonso, Paloma Terroba, González, Beatriz Fernández
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Quimioterapia 2022
Materias:	Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728602/ https://www.ncbi.nlm.nih.gov/pubmed/36164854 http://dx.doi.org/10.37201/req/040.2022

Ejemplares similares

Dosificación de cefazolina prequirúrgica en pacientes obesos y no obesos. ¿Importa el peso?
por: de Castro, Belén Rodríguez, et al.
Publicado: (2020)

Paraneoplastic Neurological Syndromes and Beyond Emerging With the Introduction of Immune Checkpoint Inhibitor Cancer Immunotherapy
por: Valencia-Sanchez, Cristina, et al.
Publicado: (2021)

The Central Role of Inflammation Associated with Checkpoint Inhibitor Treatments
por: Vajaitu, Cristina, et al.
Publicado: (2018)

Antibiotic therapy and outcome from immune-checkpoint inhibitors
por: Pinato, David J., et al.
Publicado: (2019)

Influence of Microbiome and Antibiotics on the Efficacy of Immune Checkpoint Inhibitors
por: Patel, Priyanka, et al.
Publicado: (2021)

Impact of Antibiotic Therapy and Metabolic Parameters in Non-Small Cell Lung Cancer Patients Receiving Checkpoint Inhibitors
por: Castello, Angelo, et al.
Publicado: (2021)

Cardiac toxicity of immune-checkpoint inhibitors: a clinical case of nivolumab-induced myocarditis and review of the evidence and new challenges
por: Martin Huertas, Roberto, et al.
Publicado: (2019)

Immune Checkpoint Inhibitors for the Therapy of Thymoma
por: Quilez, Alicia, et al.
Publicado: (2020)

Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of Literature
por: Albarrán, Víctor, et al.
Publicado: (2022)

Anti–Interleukin-6 and Janus Kinase Inhibitors for Severe Neurologic Toxicity of Checkpoint Inhibitors
por: Picca, Alberto, et al.
Publicado: (2021)

Response to the Article on Antibiotics and Immune Checkpoint Inhibitors by Lin et al.
por: Cheung, Ka Shing, et al.
Publicado: (2022)

Long noncoding RNA amplified in lung cancer rewires cancer pathways
por: Martínez-Terroba, Elena, et al.
Publicado: (2020)

Ultrasound-guided supraclavicular cannulation of the brachiocephalic vein may reduce central line–associated bloodstream infection in preterm infants
por: Oulego-Erroz, Ignacio, et al.
Publicado: (2020)

Checkpoint inhibitor–associated cutaneous small vessel vasculitis
por: Castillo, Brianna, et al.
Publicado: (2018)

Editorial: The Roles of Checkpoint Inhibitors in Inflammatory Diseases
por: von Knethen, Andreas, et al.
Publicado: (2021)

Antibiotics impair immune checkpoint inhibitor effectiveness in Hispanic patients with non‐small cell lung cancer (AB‐CLICaP)
por: Ruiz‐Patiño, Alejandro, et al.
Publicado: (2020)

Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer
por: Frigola, Joan, et al.
Publicado: (2021)

1196. Influence of antibiotic use on the effectiveness and safety of immune checkpoint inhibitors in Japan
por: Minamishima, Takuya, et al.
Publicado: (2020)

Effects of Concomitant Antibiotics Use on Immune Checkpoint Inhibitor Efficacy in Cancer Patients
por: Jiang, Shuai, et al.
Publicado: (2022)

Antibodies against 4 Atypical Post-Translational Protein Modifications in Patients with Rheumatoid Arthritis
por: Rodríguez-Martínez, Lorena, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor-Related Stress Cardiomyopathy: Differential Diagnosis and Key Role of Cardiac Imaging
por: Cobarro, Lucía, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance
por: Mascolo, Annamaria, et al.
Publicado: (2021)

Impact of Antibiotics and Proton Pump Inhibitors on Efficacy and Tolerance of Anti-PD-1 Immune Checkpoint Inhibitors
por: Giordan, Quentin, et al.
Publicado: (2021)

Toxicity of Immune-Checkpoint Inhibitors in Hematological Malignancies
por: Hradska, Katarina, et al.
Publicado: (2021)

Impact of tumor mutational burden on checkpoint inhibitor drug eligibility and outcomes across racial groups
por: Hsiehchen, David, et al.
Publicado: (2021)

Restricted Mean Survival Time—Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors?
por: Pîrlog, Cristina-Florina, et al.
Publicado: (2023)

The nuclear receptor NOR-1 regulates the small muscle protein, X-linked (SMPX) and myotube differentiation
por: Ferrán, Beatriz, et al.
Publicado: (2016)

A new biological triangle in cancer: intestinal microbiota, immune checkpoint inhibitors and antibiotics
por: Zhang, Jie, et al.
Publicado: (2021)

The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors
por: Zhang, Lilong, et al.
Publicado: (2022)

Small cell carcinoma of the kidney treated with immune checkpoint inhibitor/tyrosine kinase inhibitor
por: Harada, Mirii, et al.
Publicado: (2023)

Checkpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic HBV Infection
por: Hoogeveen, Ruben C., et al.
Publicado: (2020)

Expression of Sirtuin 1 and 2 Is Associated with Poor Prognosis in Non-Small Cell Lung Cancer Patients
por: Grbesa, Ivana, et al.
Publicado: (2015)

Testimonio eXcéntrico: el performance de matrimonios en desvío colectivo
por: Alarcón Múgica, Alonso
Publicado: (2018)

Imaging assessment of toxicity related to immune checkpoint inhibitors
por: Berz, Antonia M., et al.
Publicado: (2023)

Immune checkpoint inhibitors in non-small cell lung cancer: from current perspectives to future treatments—a systematic review
por: Olivares-Hernández, Alejandro, et al.
Publicado: (2023)

Use of Immune Checkpoint Inhibitors in Elderly Patients With Chronic Kidney Disease and Renal Cell Carcinoma Metastasis of the Parotid Gland: Case Report and Review of the Literature
por: Parosanu, Andreea, et al.
Publicado: (2022)

Immune checkpoint inhibitors for small cell lung cancer: opportunities and challenges
por: Regzedmaa, Orgilmaa, et al.
Publicado: (2019)

Advances in immune checkpoint inhibitors therapy for small cell lung cancer
por: Li, Longhui, et al.
Publicado: (2023)

Effects of Acetaminophen Exposure on Outcomes of Patients Receiving Immune Checkpoint Inhibitors for Advanced Non-Small-Cell Lung Cancer: A Propensity Score-Matched Analysis
por: Nelli, Fabrizio, et al.
Publicado: (2023)

Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors
por: Torrente, María, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mooeafak8fvvvdlff7bpcnkqtc